Lymphoma of cytotoxic/suppressor T cell phenotype (T<inf>8</inf>) following angioimmunoblastic lymphadenopathy

Arye Rubinstein, Leonard G. Dauber

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A patient with angioimmunoblastic lymphadenopathy was treated with chemotherapy to complete remission for 13 years. A single relapse, self-limited, occurred followed 2 years later by the appearance of a disseminated non-Hodgkin's lymphoma with prominent cutaneous lesions and hypogammaglobulinemia. Cells from the peripheral blood and an affected lymph node were characterized by immunologic studies as deriving from the T<inf>8</inf> subset of lymphocytes, suggesting a functional relationship between these suppressor cells and the patient's clinical manifestations.

Original languageEnglish (US)
Pages (from-to)195-199
Number of pages5
JournalONCOLOGY (United States)
Volume40
Issue number3
DOIs
StatePublished - 1983

Fingerprint

Immunoblastic Lymphadenopathy
Lymphoma
CD8-Positive T-Lymphocytes
T-Lymphocytes
Phenotype
Agammaglobulinemia
Non-Hodgkin's Lymphoma
Blood Cells
Lymph Nodes
Recurrence
Drug Therapy
Skin

Keywords

  • Angioimmunoblastic lymphadenopathy
  • Lymphoma
  • T<inf>8</inf> suppressor cells

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lymphoma of cytotoxic/suppressor T cell phenotype (T<inf>8</inf>) following angioimmunoblastic lymphadenopathy. / Rubinstein, Arye; Dauber, Leonard G.

In: ONCOLOGY (United States), Vol. 40, No. 3, 1983, p. 195-199.

Research output: Contribution to journalArticle

@article{330f46ae36544b21b9bb74803bea3851,
title = "Lymphoma of cytotoxic/suppressor T cell phenotype (T8) following angioimmunoblastic lymphadenopathy",
abstract = "A patient with angioimmunoblastic lymphadenopathy was treated with chemotherapy to complete remission for 13 years. A single relapse, self-limited, occurred followed 2 years later by the appearance of a disseminated non-Hodgkin's lymphoma with prominent cutaneous lesions and hypogammaglobulinemia. Cells from the peripheral blood and an affected lymph node were characterized by immunologic studies as deriving from the T8 subset of lymphocytes, suggesting a functional relationship between these suppressor cells and the patient's clinical manifestations.",
keywords = "Angioimmunoblastic lymphadenopathy, Lymphoma, T<inf>8</inf> suppressor cells",
author = "Arye Rubinstein and Dauber, {Leonard G.}",
year = "1983",
doi = "10.1159/000225724",
language = "English (US)",
volume = "40",
pages = "195--199",
journal = "Oncology",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "3",

}

TY - JOUR

T1 - Lymphoma of cytotoxic/suppressor T cell phenotype (T8) following angioimmunoblastic lymphadenopathy

AU - Rubinstein, Arye

AU - Dauber, Leonard G.

PY - 1983

Y1 - 1983

N2 - A patient with angioimmunoblastic lymphadenopathy was treated with chemotherapy to complete remission for 13 years. A single relapse, self-limited, occurred followed 2 years later by the appearance of a disseminated non-Hodgkin's lymphoma with prominent cutaneous lesions and hypogammaglobulinemia. Cells from the peripheral blood and an affected lymph node were characterized by immunologic studies as deriving from the T8 subset of lymphocytes, suggesting a functional relationship between these suppressor cells and the patient's clinical manifestations.

AB - A patient with angioimmunoblastic lymphadenopathy was treated with chemotherapy to complete remission for 13 years. A single relapse, self-limited, occurred followed 2 years later by the appearance of a disseminated non-Hodgkin's lymphoma with prominent cutaneous lesions and hypogammaglobulinemia. Cells from the peripheral blood and an affected lymph node were characterized by immunologic studies as deriving from the T8 subset of lymphocytes, suggesting a functional relationship between these suppressor cells and the patient's clinical manifestations.

KW - Angioimmunoblastic lymphadenopathy

KW - Lymphoma

KW - T<inf>8</inf> suppressor cells

UR - http://www.scopus.com/inward/record.url?scp=0020597187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020597187&partnerID=8YFLogxK

U2 - 10.1159/000225724

DO - 10.1159/000225724

M3 - Article

VL - 40

SP - 195

EP - 199

JO - Oncology

JF - Oncology

SN - 0890-9091

IS - 3

ER -